<SEC-DOCUMENT>0001654954-21-000479-index.html : 20210114 <SEC-HEADER>0001654954-21-000479.hdr.sgml : 20210114 <ACCEPTANCE-DATETIME>20210114170157 ACCESSION NUMBER: 0001654954-21-000479 CONFORMED SUBMISSION TYPE: DEF 14C PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201230 FILED AS OF DATE: 20210114 DATE AS OF CHANGE: 20210114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GT Biopharma, Inc. CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14C SEC ACT: 1934 Act SEC FILE NUMBER: 000-08092 FILM NUMBER: 21529518 BUSINESS ADDRESS: STREET 1: 9350 WILSHIRE BLVD. STREET 2: SUITE 203 CITY: BEVERLY HILLS STATE: CA ZIP: 90212 BUSINESS PHONE: (800) 304-9888 MAIL ADDRESS: STREET 1: 9350 WILSHIRE BLVD. STREET 2: SUITE 203 CITY: BEVERLY HILLS STATE: CA ZIP: 90212 FORMER COMPANY: FORMER CONFORMED NAME: OXIS INTERNATIONAL INC DATE OF NAME CHANGE: 19940916 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 </SEC-HEADER> <DOCUMENT> <TYPE>DEF 14C <SEQUENCE>1 <FILENAME>gtbp_def14c.htm <DESCRIPTION>PRIMARY DOCUMENT <TEXT> Document 1 - file: gtbp_def14c.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>gtbp_def14c000.jpg <DESCRIPTION>IMAGE <TEXT> Document 2 - file: gtbp_def14c000.jpg
</DOCUMENT> </SEC-DOCUMENT>